The First Hospital of China Medical University
The First Hospital of China Medical University
Shenyang, Liaoning, China16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenocarcinoma, carcinoma, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatocellular carcinoma, liver disorder, metabolic disease, neoplasm | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07557914 | |
| A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | cancer, neoplasm | Recruiting | Phase 1 | 2026-08-20 | NCT07660432 | |
| A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors | Advanced Solid Tumors | Active, not recruiting | Phase 1 | 2026-08-07 | NCT05502393 | |
| A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT05170958 | |
| Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-05-28 | NCT07483359 | |
| A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Not stated | 2026-02-09 | NCT07143045 | |
| Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation | Efficacy; Safety; Tolerability | Recruiting | Phase 1 / Phase 2 | 2026-01-29 | NCT06243354 | |
| First in Human Study of SIM0610 in Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, head and neck squamous cell carcinoma, hepatocellular carcinoma, intestinal disorder, liver disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2026-01-23 | NCT07348211 | |
| A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors | Advanced Malignant Tumors | Recruiting | Phase 1 | 2026-01-21 | NCT07043751 | |
| Left Ventricular Myocardial Work for Predicting Response to CRT | cardiovascular disorder, heart disorder, heart failure | Not yet recruiting | Not stated | 2026-01-06 | NCT07319065 | |
| A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, cardiovascular disorder, congenital heart disease, heart disorder, heart failure, heart septal defect, heart valve disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, tricuspid valve insufficiency, vascular disorder | Not yet recruiting | Not stated | 2025-12-18 | NCT07292896 | |
| Clinical Studies for the Treatment of Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-12-18 | NCT06825494 | |
| A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, generalized pustular psoriasis, psoriasis, skin disorder | Active, not recruiting | Phase 1 | 2025-07-30 | NCT06433531 | |
| Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue | Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment | Recruiting | Not applicable | 2025-02-17 | NCT06830018 | |
| HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Not stated | 2024-10-08 | NCT06632106 | |
| HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC | BCLC Stage B Hepatocellular Carcinoma; BCLC Stage C Hepatocellular Carcinoma; Hepatic Arterial Infusion Chemotherapy; Lenvatinib; PD-1; Systemic Therapy | Recruiting | Not stated | 2024-10-08 | NCT06632093 |